IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Pembrolizumab and Carboplatin in Treating Patients With Relapsed or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Paediatric Hepatic International Tumour Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Nivolumab, Ifosfamide, Carboplatin, and Etoposide as Second-Line Therapy in Treating Patients With Refractory or Relapsed HL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ixazomib (MLN9708) in Combination With Carboplatin in Pretreated Women With Advanced Triple Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Docetaxel and Carboplatin for Patients With mCRPC and DNA-Repair Deficiencies
- Status
- TERMINATED
- Phase
- PHASE2
Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC)
- Status
- TERMINATED
- Phase
- PHASE2
Neoadjuvant Carboplatin in Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Vibostolimab Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001) ( KEYVIBE-001)
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Study of Veliparib in Combination With Nivolumab and Platinum Doublet Chemotherapy in Participants With Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
- Status
- WITHDRAWN
- Phase
- PHASE2
Safety, PK and Efficacy of NOX66 as a Monotherapy and Combined With Carboplatin in Refractory Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC)
- Status
- TERMINATED
- Phase
- PHASE2
Multicentric Randomised Trial for Resectable Gastric Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2